LIFECORE BIOMEDICAL, INC. \DE\ financial data

Symbol
LFCR on Nasdaq
Location
Chaska, MN
Fiscal year end
25 May
Latest financial report
10-KT - Q2 2025 - 16 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 293% % 42%
Quick Ratio 113% % 6.7%
Debt-to-equity -3332% % -271%
Return On Assets -14% % -637%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37,477,386 shares 1.2%
Common Stock, Shares, Outstanding 37,477,386 shares 1.3%
Entity Public Float $222,965,066 USD
Common Stock, Value, Issued $37,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 37,402,912 shares 21%
Weighted Average Number of Shares Outstanding, Diluted 37,402,912 shares 21%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $6,637,000 USD -23%
Operating Income (Loss) $14,645,000 USD -24%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $33,826,000 USD -685%
Income Tax Expense (Benefit) $368,000 USD 426%
Net Income (Loss) Attributable to Parent $34,194,000 USD -623%
Earnings Per Share, Basic -1.1 USD/shares -624%
Earnings Per Share, Diluted -1.1 USD/shares -833%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $17,469,000 USD 85%
Accounts Receivable, after Allowance for Credit Loss, Current $30,303,000 USD
Inventory, Net $29,085,000 USD -26%
Assets, Current $82,292,000 USD 0.53%
Property, Plant and Equipment, Net $127,304,000 USD -15%
Operating Lease, Right-of-Use Asset $2,233,000 USD -11%
Intangible Assets, Net (Excluding Goodwill) $4,200,000 USD 0%
Goodwill $13,881,000 USD 0%
Other Assets, Noncurrent $8,700,000 USD 239%
Assets $232,177,000 USD -9.1%
Accounts Payable, Current $5,839,000 USD -61%
Employee-related Liabilities, Current $4,548,000 USD -1.8%
Accrued Liabilities, Current $17,734,000 USD
Contract with Customer, Liability, Current $8,660,000 USD
Liabilities, Current $23,573,000 USD -33%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Deferred Income Tax Liabilities, Net $552,000 USD 33%
Operating Lease, Liability, Noncurrent $1,120,000 USD
Other Liabilities, Noncurrent $6,698,000 USD 30%
Liabilities $198,117,000 USD 1.3%
Retained Earnings (Accumulated Deficit) $223,201,000 USD -17%
Stockholders' Equity Attributable to Parent $14,202,000 USD -192%
Liabilities and Equity $232,177,000 USD -9.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,762,000 USD
Net Cash Provided by (Used in) Financing Activities $1,388,000 USD -227%
Net Cash Provided by (Used in) Investing Activities $1,737,000 USD 49%
Common Stock, Shares Authorized 75,000,000 shares 0%
Common Stock, Shares, Issued 37,477,386 shares 1.3%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,363,000 USD 54%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $17,469,000 USD 85%
Interest Paid, Excluding Capitalized Interest, Operating Activities $265,000 USD -58%
Deferred Tax Assets, Valuation Allowance $57,538,000 USD
Deferred Tax Assets, Gross $74,140,000 USD
Operating Lease, Liability $1,492,000 USD
Depreciation $1,981,000 USD -0.6%
Payments to Acquire Property, Plant, and Equipment $1,737,000 USD -49%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $12,013,000 USD 82%
Lessee, Operating Lease, Liability, to be Paid $1,617,000 USD
Property, Plant and Equipment, Gross $186,464,000 USD -9%
Operating Lease, Liability, Current $372,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two $414,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $410,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.0302 pure -0.66%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $125,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $144,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $42,091,000 USD
Preferred Stock, Shares Issued 44,068 shares 7.5%
Preferred Stock, Shares Authorized 2,000,000 shares 0%
Unrecognized Tax Benefits $1,461,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $148,000 USD
Operating Lease, Payments $102,000 USD 0.99%
Additional Paid in Capital $208,962,000 USD 1%
Preferred Stock, Shares Outstanding 44,068 shares 7.5%
Depreciation, Depletion and Amortization $1,981,000 USD -0.6%
Deferred Tax Assets, Net of Valuation Allowance $16,602,000 USD
Share-based Payment Arrangement, Expense $8,882,000 USD 84%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%